DOP1990004772A - Un procedimiento para la preparacion de acidos y esteresde aminociclopentanol - Google Patents

Un procedimiento para la preparacion de acidos y esteresde aminociclopentanol

Info

Publication number
DOP1990004772A
DOP1990004772A DO1990004772A DO1990004772A DOP1990004772A DO P1990004772 A DOP1990004772 A DO P1990004772A DO 1990004772 A DO1990004772 A DO 1990004772A DO 1990004772 A DO1990004772 A DO 1990004772A DO P1990004772 A DOP1990004772 A DO P1990004772A
Authority
DO
Dominican Republic
Prior art keywords
esters
acids
procedure
preparation
amino cyclopentanol
Prior art date
Application number
DO1990004772A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DOP1990004772A publication Critical patent/DOP1990004772A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DO1990004772A 1981-04-29 1990-01-15 Un procedimiento para la preparacion de acidos y esteresde aminociclopentanol DOP1990004772A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8113238 1981-04-29

Publications (1)

Publication Number Publication Date
DOP1990004772A true DOP1990004772A (es) 1996-02-02

Family

ID=10521483

Family Applications (1)

Application Number Title Priority Date Filing Date
DO1990004772A DOP1990004772A (es) 1981-04-29 1990-01-15 Un procedimiento para la preparacion de acidos y esteresde aminociclopentanol

Country Status (4)

Country Link
JP (1) JPS57183772A (enExample)
DO (1) DOP1990004772A (enExample)
GB (1) GB2097397B (enExample)
ZA (1) ZA822933B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5973576A (ja) * 1982-09-16 1984-04-25 グラクソ・グル−プ・リミテツド ピペリジニルシクロペンタノ−ルヘプテン酸塩
GB2127406B (en) * 1982-09-16 1986-03-05 Glaxo Group Ltd Piperidinlycyclopentanolheptenoic acid salt
AU576476B2 (en) * 1982-09-16 1988-09-01 Glaxo Group Limited Piperidinylcyclopentanol heptenoic acid salt
ZA838018B (en) * 1982-10-28 1984-06-27 Glaxo Group Ltd Preparation of aminocyclopentane acids
GB8307099D0 (en) * 1983-03-15 1983-04-20 Glaxo Group Ltd Carbocyclic compounds
DK422984A (da) * 1983-09-06 1985-03-07 Glaxo Group Ltd Aminocyklopentaner og farmaceutiske praeparater deraf
GB8601985D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Chemical process
US4968703A (en) * 1986-08-08 1990-11-06 Glaxo Group Limited Pharmaceutical compositions for the treatment of occlusive vascular diseases
GB8715333D0 (en) * 1987-06-30 1987-08-05 Glaxo Group Ltd Process
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
ZW18088A1 (en) * 1987-12-22 1989-07-26 Glaxo Group Ltd Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative
GB8811311D0 (en) * 1988-05-12 1988-06-15 Glaxo Group Ltd Medicaments
GB8814725D0 (en) * 1988-06-21 1988-07-27 Glaxo Group Ltd Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7906017L (sv) * 1978-07-11 1980-02-13 Glaxo Group Ltd Prostanoida foreningar
ZA81114B (en) * 1980-01-09 1982-01-27 Glaxo Group Ltd Prostanoid compounds and their preparation and pharmaceutical formalation

Also Published As

Publication number Publication date
JPH0352456B2 (enExample) 1991-08-12
ZA822933B (en) 1983-04-27
GB2097397B (en) 1984-09-19
JPS57183772A (en) 1982-11-12
GB2097397A (en) 1982-11-03

Similar Documents

Publication Publication Date Title
ES501740A0 (es) Un procedimiento para preparar acidos y esteres aminociclo- pentano-alquenoicos
AR230268A1 (es) Procedimiento para la preparacion de acidos y esteres 4-amino-3-quinolincarboxilicos
ES496166A0 (es) Un procedimiento para la preparacion de acidos 6-b-hidroxialquilpenicilanicos y sus derivados.
MX7222E (es) Procedimiento para la preparacion de amido-aminoacidos n-substituidos
AR231279A1 (es) Un procedimiento para la preparacion de 2-2-benoil-3-mercaptopropionil amino-4-metiltio-butanoles quirales y acidos 2-2-bencil-3-metilmercaptopropionilamino-4-metil-tiobutiricos quirales
ES488684A0 (es) Un procedimiento para la preparacion de esteres arilaceticos
ES555840A0 (es) Un procedimiento para la desproteccion de esteres y eteres alilicos
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES534186A0 (es) Un procedimiento para la preparacion de derivados peptidicos
AR231270A1 (es) Un procedimiento para la preparacion de esteres alifaticos c1-6 de acidonitroso en estado de vapor
ES556465A0 (es) Un procedimiento para la preparacion de nuevos acidos cefalosporanicos y sus esteres.
ES492955A0 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
MX160593A (es) Procedimiento para la preparacion de esteres de biotina
AR225758A1 (es) Un procedimiento para la preparacion de acidos penicilanicos 6 beta-sustituidos
ES494878A0 (es) Un procedimiento para la preparacion de (a)-esteres de acidohexahidrobenzoico y otros acidos carboxilicos alifaticos o cicloalifaticos
ES492367A0 (es) Un procedimiento para la preparacion de esteres de acidos ciclohexencarboxilicos
ES548427A0 (es) Un procedimiento para la preparacion de acidos 6-metilen sustituido penicilanicos y derivados de los mismos
ES519679A0 (es) Procedimiento para la preparacion de acidos fenilamino-oxo-aceticos y sus esteres.
ES507916A0 (es) Un procedimiento para la preparacion de-amino acidos n-sustituidos.
ES512769A0 (es) "procedimiento para la preparacion de esteres 2-metoxifenilicos de aminoacidos n-substituidos".
ES539487A0 (es) Un procedimiento para la preparacion de esteres alfa-metil- (6-fenoxi)-2-picolilicos de acidos ciclopropancarboxilicos
ES494168A0 (es) Un procedimiento para la preparacion de acidos alfa-aril- propionicos
ES544220A0 (es) Un procedimiento para la obtencion de acidos alquencarboxi- licos
ES514456A0 (es) "un procedimiento para la preparacion de esteres de 2-tenoilmercaptopropionilglicina".
ES516909A0 (es) Un procedimiento para la preparacion de acidos aminociclopentanoalquenoicos.